Immune pathomechanism of drug hypersensitivity reactions
Authors:
- Werner J. PichlerWPWerner J. Pichler
- Dean J. NaisbittDNDean J. Naisbitt
- B. Kevin ParkBPB. Kevin Park
- 1 March 2011
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 127 (3) , S74-S81
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Drug Hypersensitivity Reactions: Pathomechanism and Clinical SymptomsMedical Clinics of North America, 2010
- Stimulation of human T cells with sulfonamides and sulfonamide metabolitesJournal of Allergy and Clinical Immunology, 2010
- The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting DrugImmunology and Allergy Clinics of North America, 2009
- Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1Toxicology and Applied Pharmacology, 2009
- Characterisation of flucloxacillin and 5‐hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivoProteomics – Clinical Applications, 2009
- Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug HypersensitivityImmunity, 2008
- HLA-B∗1502–bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndromeJournal of Allergy and Clinical Immunology, 2007
- Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to β-lactamsJournal of Allergy and Clinical Immunology, 2006
- Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactionsJournal of Allergy and Clinical Immunology, 2006
- Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cellsJournal of Allergy and Clinical Immunology, 2004